Diamyd Medical AB (publ) (STO: DMYD.B)

Diamyd Medical AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	17.25	61.5	11.19	24.78	6.45	9.55
Depreciation & Amortization	11.82	9.72	6.63	5.77	5.43	3.5
Asset Writedown & Restructuring Costs	-	-	-	-	-	3.46
Other Operating Activities	5.91	-6.85	-3.95	-0.39	-4.3	0.12
Change in Accounts Receivable	-8.71	-8.71	-14.34	0.88	-5.29	-2.31
Change in Inventory	-2.35	-2.35	-0.14	0.47	-3.92	-3.23
Change in Accounts Payable	14.44	14.44	-0.32	14.41	5.38	2.04
Operating Cash Flow	37.28	67.75	-0.93	45.92	3.76	13.13
Operating Cash Flow Growth	-23.59%	-	-	1122.81%	-71.39%	-
Capital Expenditures	-6.02	-10.44	-2.93	-1.77	-1.43	-4.18
Sale (Purchase) of Intangibles	-3.88	-2.37	-0.89	-2.72	-19	-0.98
Investing Cash Flow	-9.87	-12.81	-3.83	-4.49	-20.43	-5.15
Long-Term Debt Repaid	-	-4.51	-3.73	-4.23	-3.77	-2.56
Net Debt Issued (Repaid)	-4.51	-4.51	-3.73	-4.23	-3.77	-2.56
Issuance of Common Stock	-	-	-	-	49.57	-
Other Financing Activities	-1.28	-	-	-	-	-
Financing Cash Flow	-5.8	-4.51	-3.73	-4.23	45.8	-2.56
Net Cash Flow	21.61	50.43	-8.49	37.2	29.13	5.41
Free Cash Flow	31.25	57.31	-3.86	44.15	2.32	8.95
Free Cash Flow Growth	-24.44%	-	-	1801.43%	-74.05%	-
Free Cash Flow Margin	24.44%	36.03%	-3.73%	47.13%	3.80%	14.78%
Free Cash Flow Per Share	0.48	0.88	-0.06	0.67	0.04	0.14
Cash Interest Paid	2.26	2.26	0.34	0.15	0.99	0.4
Levered Free Cash Flow	13.69	29.75	-2.79	28.32	-19.05	4.45
Unlevered Free Cash Flow	15.1	31.16	-2.57	28.32	-18.43	4.7
Change in Net Working Capital	2.33	0.05	14.02	-12.56	6.66	-0.08

Source: S&P Capital IQ. Standard template. Financial Sources.